FOUNDERS GROVE WEALTH PARTNERS, LLC

Position in LLY — ELI LILLY & Co

CIK 2046157 RICHMOND, VA

Position in LLY

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$18,430,442

+$2,454,038 QoQ

Shares Held

15,366

-11.5% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

18.43%

of 13F equity value

Holder Rank

#921

of 4,605 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

FOUNDERS GROVE WEALTH PARTNERS, LLC holds $22,439,048 across 6 Drug Manufacturers - General names. LLY ranks #1 (82.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	15,366	$18,430,442
2	JNJ	Johnson & Johnson	8,327	$2,114,808
3	ABBV	AbbVie Inc.	2,939	$739,569
4	MRK	Merck & Co., Inc.	4,961	$637,488
5	GILD	Gilead Sciences, Inc.	2,346	$296,393
6	NVS	Novartis AG	1,406	$220,348

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,430,442	15,366	-11.5%	Shares	Sole	2026-07-22
2026-03-31	$15,976,404	17,370	-0.3%	Shares	Sole	2026-04-15
2025-12-31	$18,714,479	17,414	-18.5%	Shares	Sole	2026-01-12
2025-09-30	$16,305,310	21,370	-0.4%	Shares	Sole	2025-10-17
2025-06-30	$16,728,713	21,460	+0.3%	Shares	Sole	2025-07-28
2025-03-31	$17,673,648	21,399	-4.3%	Shares	Sole	2025-04-16
2024-12-31	$17,257,288	22,354	—	Shares	Sole	2025-01-14
No filing history on record for this holder in this stock.